Clinical, demographic and instrumental characteristics of patients with chronic heart failure and reduced left ventricular ejection fraction depending on iron deficiency
Journal Title: Серце і судини - Year 2018, Vol 0, Issue 2
Abstract
The aim — to establish clinical and other factors associated with iron deficiency (ID) in patients with chronic heart failure (CHF) and reduced left ventricular (LV) ejection fraction (EF). Materials and methods. 134 stable patients with CHF (113 (84.3 %) men and 21 (15.7 %) women), 18 — 75 years old, NYHA class II — IV, with left ventricular ejection fraction < 40 % were screened on a basis of the Heart Failure Department of the National Scientific Center «M. D. Strazhesko Institute of Cardiology» of NAMS of Ukraine in the period from January 13, 2016 till February 28, 2018. Patients were included in a clinical compensation phase. Quality of life was assessed by the Minnesota living with heart failure questionnaire (MLHFQ), physical activity was estimated by the Duke University index, functional status — by assessing the 6minute walking test (6MWT) and a standardized lower limb extension test. Results and discussion. ID was found in 83 (61.9 %) of 134 patients with CHF and reduced LVEF. They did not differ in regard of presence of coronary artery disease, arterial hypertension, dilated cardiomyopathy, myocardial infarction, persistent/long standing form of atrial fibrillation, chronic obstructive pulmonary disease and diabetes mellitus. There were no significant differences in demographic, clinical and instrumental indices such as gender, age, heart rate, enddiastolic volume index, brachial artery flowdependent vasodilation in groups with and without ID. However, patients with ID were in more severe (III — IV) NYHA class and inclined to have anemia and worse renal dysfunction. The ID group was characterized by a slightly lower body mass index (BMI) and level of systolic blood pressure (SBP), a higher Nterminal prohormone of brain natriuretic peptide (NTproBNP) level, a lower hemoglobin, lower MCV, MCH, a higher interleukin6 (IL6) level, and a lower glomerular filtration rate, as well as a worse quality of life by MLHFQ, worse 6MWT and lower limb extension test results. Ferritin has shown a significant direct correlation with serum iron levels, MCV, MCH, hemoglobin and BMI levels. Transferrin saturation (TSAT) level directly correlated with a serum iron level, hemoglobin, MCV and MCH levels, limb muscles endurance, 6minute walking test result, SBP, BMI, physical activity index and reversely correlated with citrulline, NTproBNP, IL6 levels in blood plasma and MLHFQ score. Conclusions. Iron deficiency was observed in 62 % of patients with CHF and reduced LVEF. CHF patients with reduced LVEF and ID versus CHF patients with reduced LVEF without ID had a higher NYHA III — IV class patients percentage, a greater proportion of patients with anemia and greater renal dysfunction, lower BMI, SBP, lower hemoglobin, MCV, MCH; higher NTproBNP, IL6, citrulline levels; worse quality of life, lower physical activity index, lesser 6MWT distance and lesser quadriceps femoris muscle endurance. Unlike the ferritin plasma level, that correlates only with hemoglobin level and iron metabolism indices, TSAT showed the connection not only with the indicated parameters, but also with the BMI, SBP, physical activity index, 6MWT, quadriceps femoris muscle endurance (direct correlation) and with citrulline, IL6, NTproBNP plasma levels and quality of life by MLHFQ (reverse correlation).
Authors and Affiliations
L. G. Voronkov, V. V. Gorbachova, A. V. Lyashenko, T. I. Gavrilenko, L. S. Mhitaryan
Keywords
Related Articles
- EP ID EP332291
- DOI 10.30978/HV2018231
- Views 107
- Downloads 0
Register of percutaneous coronary interventions: expanded comparative analysis of results of 2016 and 20 17. From reperfusion paradox to decrease of mortality
Ukrainian Association of Interventional Cardiology established Percutaneous Coronary Interventions Registry (PCI Registry) in 2010. The first protocol was filled on 12.04.2010. By now (23.07.2018, 17 h 58 min) the Regist...
Heterogeneity of patients with arterial hypertension and heart failure with preserved left ventricular ejection fraction according to the clinical and structural-functional profile of the heart and arteries depending on the available diagnostic criteria of the European Society of Cardiology (2016)
The aim — to determine the frequency of different combinations of criteria of heart failure (HF) with preserved ventricular ejection fraction (EF), established by the European Society of Cardiology (ESC) in 2016, in symp...
Prognostic significance of soluble ST2 as predictor of late left ventricular remodeling after ST-segment elevation myocardial infarction
The aim — to study the prognostic value of soluble ST2 regarding the development of pathological left ventricular remodeling (LVR) 6 months after acute ST‑ segment elevation myocardial infarction (STEMI) Materials and m...
Peripheral blood leukocyte count and prognosis in patients with myocardial infarction treated with thrombolytic therapy
The aim — to evaluate the predictive value of peripheral blood leukocyte count regarding the efficacy of thrombolytic therapy (TLT) and STEMI clinical course. Materials and methods. We examined 100 patients with STEMI a...
Comparison of clinical characteristics of patients with chronic heart failure and reduced left ventricular ejection fraction in regard of state of cognitive function
The aim — to establish clinical factors associated with cognitive dysfunction (CD) in patients with chronic heart failure (CHF) and reduced left ventricular ejection fraction (LV EF). Materials and methods. We examined...